Management of Parkinson's Disease: Defining the Role of Entacapone
Year of publication: |
2002
|
---|---|
Authors: | Ibbotson, Tim ; Goa, Karen L. |
Published in: |
Disease Management and Health Outcomes. - Springer Healthcare | Adis, ISSN 1173-8790. - Vol. 10.2002, 10, p. 643-659
|
Publisher: |
Springer Healthcare | Adis |
Subject: | Acetylcholine receptor antagonists | Amantadine | Catechol O methyltransferase inhibitors | Dopamine receptor agonists | Entacapone | Levodopa | Parkinson's disease | Surgery |
Extent: | application/pdf text/html |
---|---|
Type of publication: | Article |
Classification: | C - Mathematical and Quantitative Methods ; D - Microeconomics ; I - Health, Education, and Welfare ; Z - Other Special Topics ; I1 - Health ; I19 - Health. Other ; I18 - Government Policy; Regulation; Public Health ; I11 - Analysis of Health Care Markets |
Source: |
-
Economic and Health-Related Quality of Life Considerations of New Therapies in Parkinson's Disease
Rubenstein, Linda M., (2001)
-
Cost-Effectiveness Analysis of Dopamine Agonists in the Treatment of Parkinson's Disease in Japan
Shimbo, Takuro, (2001)
-
The Economic Impact of Parkinson`s Disease: An Estimation Based on a 3-Month Prospective Analysis
Dodel, Richard C., (1998)
- More ...
-
Management of Alzheimer's Disease: Defining the Role of Donepezil
Ibbotson, Tim, (2002)
-
Spotlight on Eptifibatide in Percutaneous Coronary Intervention and Acute Coronary Syndromes
Plosker, Greg L., (2004)
-
Plosker, Greg L., (2003)
- More ...